DNER, a noncanonical Notch ligand, was found to suppress glioma growth by inhibiting the oncogene TOR4A [58] and hindered the growth and induced differentiation of GBM-derived neurospheres [59]. The gene discussed is TOR4A; the disease is central nervous system cancer.